Segall Bryant & Hamill LLC Trims Position in Option Care Health, Inc. (NASDAQ:OPCH)

Segall Bryant & Hamill LLC cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 3.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 281,870 shares of the company's stock after selling 9,439 shares during the quarter. Segall Bryant & Hamill LLC owned about 0.17% of Option Care Health worth $9,851,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in OPCH. JPMorgan Chase & Co. grew its stake in Option Care Health by 29.6% during the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after purchasing an additional 344,875 shares during the last quarter. Compass Wealth Management LLC lifted its stake in Option Care Health by 8.9% during the 1st quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock valued at $5,804,000 after acquiring an additional 13,600 shares during the period. Bessemer Group Inc. boosted its holdings in shares of Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after acquiring an additional 599 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in shares of Option Care Health by 1.4% in the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock valued at $16,981,000 after acquiring an additional 6,616 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its stake in shares of Option Care Health by 25.7% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock worth $289,000 after acquiring an additional 1,691 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a report on Wednesday, June 18th. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. Finally, Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Thursday, July 10th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Price Performance

Option Care Health stock traded down $0.46 during midday trading on Friday, reaching $29.48. The company had a trading volume of 954,581 shares, compared to its average volume of 1,828,047. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.54 and a quick ratio of 1.02. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a market capitalization of $4.83 billion, a P/E ratio of 21.85, a P/E/G ratio of 1.81 and a beta of 0.73. The firm's fifty day simple moving average is $31.62 and its 200-day simple moving average is $31.57.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same quarter in the prior year, the firm earned $0.26 earnings per share. The business's revenue was up 16.3% compared to the same quarter last year. As a group, equities analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.